Figure 2
From: Overcoming cisplatin resistance by mTOR inhibitor in lung cancer
Westernblot analysis of mTOR in Lane1: SCLCB, Lane 2: SCLCBC. Lane 3: SR-2, Lane 4: SCLC1. Note: there are no differences in mTOR levels in these 4 cell lines.
Figure 2 | Molecular Cancer